1-3 of 3
Shilpi Arora
Close
Sort by
Journal Articles

EZH2 Inhibitors Are Broadly Efficacious in Multiple Myeloma As Single Agent and in Combination with Standard of Care Therapeutics

Shilpi Arora, PhD, Kaylyn Williamson, BS, Shruti Apte, BS, Srividya Balachander, PhD, Jennifer Busby, PhD, Charlie Hatton, PhD, Barbara Bryant, PhD, Patrick Trojer, PhD
Journal: Blood
Blood (2016) 128 (22): 5672.
https://doi.org/10.1182/blood.V128.22.5672.5672
Published: 2016
Journal Articles

RNAi screening of the kinome with cytarabine in leukemias

Raoul Tibes, James M. Bogenberger, Leena Chaudhuri, R. Tanner Hagelstrom, Donald Chow, Megan E. Buechel, Irma M. Gonzales, Tim Demuth, James Slack, Ruben A. Mesa, Esteban Braggio, Hongwei H. Yin, Shilpi Arora, David O. Azorsa
Journal: Blood
Blood (2012) 119 (12): 2863–2872.
https://doi.org/10.1182/blood-2011-07-367557
Published: 2012
Includes: Supplemental data
Journal Articles

RNAi Screening of the Human Kinome Identifies Inhibition of WEE1 Kinase As Potent and Universal Sensitizing Target to Cytarabine in Leukemias

Raoul Tibes, MD, PhD, Leena Chaudhuri, PhD, James M Bogenberger, PhD, Tanner R Hagelstrom, PhD, MBA, Amanda McNally, MS, Donald Chow, Megan E Buechel, MS, Irma Gonzales, Esteban Braggio, PhD, Hongwei Yin, PHD, Shilpi Arora, PhD, David Azorsa, PhD, Craig B. Reeder, MD, Pierre Noel, MD, James L. Slack, MD, Ruben A. Mesa, MD, Tim Demuth, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 229.
https://doi.org/10.1182/blood.V118.21.229.229
Published: 2011